ENSG00000081248


Homo sapiens

Features
Gene ID: ENSG00000081248
  
Biological name :CACNA1S
  
Synonyms : CACNA1S / calcium voltage-gated channel subunit alpha1 S / Q13698
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 1
Strand: -1
Band: q32.1
Gene start: 201039512
Gene end: 201112566
  
Corresponding Affymetrix probe sets: 217515_s_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000355192
Ensembl peptide - ENSP00000356307
NCBI entrez gene - 779     See in Manteia.
OMIM - 114208
RefSeq - NM_000069
RefSeq - XM_005245478
RefSeq Peptide - NP_000060
swissprot - B1ALM3
swissprot - Q13698
Ensembl - ENSG00000081248
  
Related genetic diseases (OMIM): 170400 - Hypokalemic periodic paralysis, type 1, 170400
  188580 - {Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580
  601887 - {Malignant hyperthermia susceptibility 5}, 601887
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 cacna1saENSDARG00000029457Danio rerio
 cacna1sbENSDARG00000042552Danio rerio
 CACNA1SENSGALG00000037744Gallus gallus
 Cacna1sENSMUSG00000026407Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
Q13936 / CACNA1C / calcium voltage-gated channel subunit alpha1 CENSG0000015106765
Q01668 / CACNA1D / calcium voltage-gated channel subunit alpha1 DENSG0000015738864
O60840 / CACNA1F / calcium voltage-gated channel subunit alpha1 FENSG0000010200158
O00555 / CACNA1A / calcium voltage-gated channel subunit alpha1 AENSG0000014183741
Q00975 / CACNA1B / calcium voltage-gated channel subunit alpha1 BENSG0000014840841
Q15878 / CACNA1E / calcium voltage-gated channel subunit alpha1 EENSG0000019821640
NALCN / Q8IZF0 / sodium leak channel, non-selectiveENSG0000010245219
Q8NEC5 / CATSPER1 / cation channel sperm associated 1ENSG000001752948


Protein motifs (from Interpro)
Interpro ID Name
 IPR002077  Voltage-dependent calcium channel, alpha-1 subunit
 IPR005446  Voltage-dependent calcium channel, L-type, alpha-1 subunit
 IPR005450  Voltage-dependent calcium channel, L-type, alpha-1S subunit
 IPR005821  Ion transport domain
 IPR014873  Voltage-dependent calcium channel, alpha-1 subunit, IQ domain
 IPR031649  Voltage-dependent L-type calcium channel, IQ-associated domain


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0006811 ion transport IEA
 biological_processGO:0006816 calcium ion transport IEA
 biological_processGO:0006936 muscle contraction IMP
 biological_processGO:0034765 regulation of ion transmembrane transport IEA
 biological_processGO:0055085 transmembrane transport IEA
 biological_processGO:0061337 cardiac conduction TAS
 biological_processGO:0070588 calcium ion transmembrane transport IEA
 biological_processGO:0071313 cellular response to caffeine ISS
 biological_processGO:0086010 membrane depolarization during action potential IBA
 cellular_componentGO:0005737 cytoplasm IDA
 cellular_componentGO:0005886 plasma membrane TAS
 cellular_componentGO:0005891 voltage-gated calcium channel complex IDA
 cellular_componentGO:0016020 membrane IEA
 cellular_componentGO:0016021 integral component of membrane IEA
 cellular_componentGO:0030315 T-tubule IDA
 cellular_componentGO:0031674 I band IDA
 cellular_componentGO:0042383 sarcolemma IEA
 cellular_componentGO:1990454 L-type voltage-gated calcium channel complex ISS
 molecular_functionGO:0005216 ion channel activity IEA
 molecular_functionGO:0005244 voltage-gated ion channel activity IEA
 molecular_functionGO:0005245 voltage-gated calcium channel activity IDA
 molecular_functionGO:0005262 calcium channel activity IEA
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0005516 calmodulin binding IEA
 molecular_functionGO:0008331 high voltage-gated calcium channel activity IDA
 molecular_functionGO:0046872 metal ion binding IEA


Pathways (from Reactome)
Pathway description
NCAM1 interactions
Phase 0 - rapid depolarisation
Phase 2 - plateau phase


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000016 Urinary retention 
Show

 HP:0000597 Ophthalmoparesis "Ophthalmoplegia is a paralysis or weakness of one or more of the muscles that control eye movement." [HPO:curators]
Show

 HP:0000975 Hyperhidrosis "An abnormally increased perspiration." [HPO:probinson]
Show

 HP:0001265 Hyporeflexia 
Show

 HP:0001337 Tremor "An unintentional, oscillating to-and-fro muscle movement." [HPO:curators]
Show

 HP:0001513 Obesity "A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY)." [MeSH:D009765]
Show

 HP:0001657 Prolonged QT interval on EKG 
Show

 HP:0001663 Ventricular fibrillation 
Show

 HP:0001824 Weight loss 
Show

 HP:0001962 Palpitations 
Show

 HP:0002019 Constipation 
Show

 HP:0002153 Hyperkalemia 
Show

 HP:0002203 Respiratory paralysis 
Show

 HP:0002445 Tetraplegia 
Show

 HP:0002900 Hypokalemia 
Show

 HP:0002917 Hypomagnesemia 
Show

 HP:0003198 Myopathy 
Show

 HP:0003201 Rhabdomyolysis 
Show

 HP:0003394 Muscle cramps 
Show

 HP:0003457 Abnormal EMG findings "Abnormal results of investigations using electromyography (EMG)." [HPO:curators]
Show

 HP:0003552 Muscle stiffness 
Show

 HP:0003694 Proximal muscle weakness occurs later "Lack of strength of the proximal musculature occuring late in the clinical course." [HPO:curators]
Show

 HP:0003752 Flaccid weakness or paralysis, episodic attacks 
Show

 HP:0003829 Incomplete penetrance 
Show

 HP:0005165 Shortened P-R interval on EKG 
Show

 HP:0007215 Secondary hyperkalemic periodic paralysis 
Show

 HP:0007340 Lower limb muscle weakness "Weakness of the muscles of the legs." [HPO:curators]
Show

 HP:0008153 Periodic hypokalemic paresis 
Show

 HP:0008180 Mildly elevated creatine phosphokinase 
Show

 HP:0008256 Adrenocortical adenoma "Adrenocortical adenomas are benign tumors of the adrenal cortex." [HPO:curators]
Show

 HP:0008285 Transient hypophosphatemia 
Show

 HP:0009020 Exercise-induced muscle fatigue "An abnormally increased tendency towards muscle fatigue induced by physical exercise." [HPO:curators]
Show

 HP:0011706 Second degree atrioventricular block "An intermittent atrioventricular block with failure of some atrial impulses to conduct to the ventricles, i.e., some but not all atrial impulses are conducted through the atrioventricular node and trigger ventricular contraction." [DDD:dbrown, HPO:probinson]
Show

 HP:0011785 Thyrotoxicosis with toxic multinodular goitre 
Show

 HP:0011786 Thyrotoxicosis with toxic single thyroid nodule 
Show

 HP:0011998 Postprandial hyperglycemia "An `increased concentration` (PATO:0001162) of `glucose` (CHEBI:17234) in the `blood` (FMA:9670) following a meal." [HPO:probinson]
Show

 HP:0012240 Increased intramyocellular lipid droplets "An abnormal increase in intracellular lipid droplets In a muscle. The number and size of these drops can increase with somd disorders of lipid metabolism affecting muscle. See pmid 20691590 for histological images." [HPO:probinson, pmid:20691590]
Show

 HP:0012364 Decreased urinary potassium "A decreased concentration of `potassium(1+)` (CHEBI:29103) in the `urine` (FMA:12274)." [HPO:probinson]
Show

 HP:0012726 Episodic hypokalemia "An abnormally decreased potassium concentration in the blood occurring periodically with a return to normal between the episodes." [HPO:probinson]
Show

 HP:0030196 Fatigable weakness of respiratory muscles "A type of weakness of the muscles involved in breathing (respiration) that occurs after a muscle group is used and lessens if the muscle group has some rest. That is, there is diminution of strength with repetitive muscle actions." [UNCL:mbertoli]
Show

 HP:0100647 Graves disease "An autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones (a serious metabolic imbalance known as hyperthyroidism and thyrotoxicosis). This is caused by autoantibodies to the TSH-receptor (TSHR-Ab) that activate that TSH-receptor (TSHR), thereby stimulating thyroid hormone synthesis and secretion, and thyroid growth (causing a diffusely enlarged goiter). The resulting state of hyperthyroidism can cause a dramatic constellation of neuropsychological and physical signs and symptoms, which can severely compromise the patients." [HPO:sdoelken]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000007402 Q9NY47 / CACNA2D2 / calcium voltage-gated channel auxiliary subunit alpha2delta 2  / complex
 ENSG00000151062 Q7Z3S7 / CACNA2D4 / calcium voltage-gated channel auxiliary subunit alpha2delta 4  / complex
 ENSG00000157445 Q8IZS8 / CACNA2D3 / calcium voltage-gated channel auxiliary subunit alpha2delta 3  / complex
 ENSG00000153956 P54289 / CACNA2D1 / calcium voltage-gated channel auxiliary subunit alpha2delta 1  / complex
 ENSG00000167535 CACNB3 / P54284 / calcium voltage-gated channel auxiliary subunit beta 3  / complex
 ENSG00000165995 CACNB2 / Q08289 / calcium voltage-gated channel auxiliary subunit beta 2  / complex
 ENSG00000067191 CACNB1 / Q02641 / calcium voltage-gated channel auxiliary subunit beta 1  / complex
 ENSG00000182389 CACNB4 / O00305 / calcium voltage-gated channel auxiliary subunit beta 4  / complex






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr